Pharyngitis Treatment Market Share

Regionally, the pharyngitis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America industry is predicted to dominate majority revenue share by 2036, impelled by high healthcare expenditure, highest health awareness among people, and increasing investment in R&D activities. As per another report by WHO, the per capita healthcare expenditure of North America valued USD 10,050.279, in 2018. Moreover, presence of major pharmaceutical companies, along with high investment in development and distribution of vaccines, is estimated to boost the market growth. The market in the Asia Pacific region is estimated to witness highest CAGR over the forecast period, owing to the high prevalence of pharyngitis backed by high population and increasing risk of infections. Moreover, growing public healthcare system in countries, such as, India, and China, is projected to further boost the pharyngitis treatment market growth.